市場調査レポート
商品コード
1319150

画像診断の世界市場-2023年~2030年

Global Diagnostic Imaging Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
画像診断の世界市場-2023年~2030年
出版日: 2023年07月31日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の画像診断市場は、2022年に274億米ドルに達し、2030年には416億米ドルに達すると予測され、予測期間中(2023-2030年)のCAGRは5.5%です。慢性疾患や病的疾患を抱える人々の増加により、前衛的な医療用画像診断の必要性が高まっています。

病態を早期に発見できる診断装置に対するニーズの高まりが、先進的な医療用画像診断装置の市場を拡大しています。技術の向上により、画像を確認した後に必要な報告期間も大幅に短縮されました。画像診断装置の精度と正確さは、技術のアップグレードによってさらに向上しています。

市場力学

製品認可の増加が画像診断市場の成長を促進

新興国市場の開拓は、予測期間中の世界の医療用画像診断市場の成長を後押しすると期待されています。例えば、2022年4月、ウィプロGEヘルスケアは次世代CTスキャナRevolution Aspireを発表しました。Revolution Aspireは、インドで開発され、エンドツーエンドで製造された先進的な画像ソリューションです。

さらに2023年2月、ヘルスケアイメージングと情報システムのフロンティアである富士フイルムインドは、インド放射線画像学会(IRIA)の第75回全国会議で製品とソリューションのポートフォリオを拡大しました。超音波診断装置Arietta 850 DeepInsightとArietta 650 DeepInsightに加え、MRI装置APERTO Lucent Non-DICOMプリンターAPEOSを発表しました。さらに、サービス&サポートモバイルアプリ「FUJIFILM Connect」も発表しました。

研究費の増加が世界の画像診断市場に成長機会をもたらすと期待される

研究費の増加は、今後数年間、世界の画像診断市場に有望な成長機会をもたらすと期待されています。例えば、R&E財団の任務は、研究者を設計し、生涯独創的な調査と教育を支援することにより、放射線医学の未来に資金を提供することです。1984年の設立以来、財団は1,600件以上の助成金を交付してきました。これは、放射線学の調査と患者ケアの向上のための資金として7,000万米ドルに相当します。

熟練した人材の不足と効率的なトレーニングプログラムが、推定・予測期間中の世界の画像診断市場の妨げになる

訓練を受けた人材の不足は、画像診断業界が直面しているかなりの課題です。画像診断は、専門的なトレーニングと専門知識を必要とする高度に専門的な分野であり、熟練した人材の不足が深刻化しています。

熟練人材不足の主な理由の1つは、画像診断の教育訓練プログラムへの投資不足です。多くの大学や専門学校は画像診断の専門プログラムを提供しておらず、画像診断のためのトレーニングプログラムの数も限られています。

COVID-19影響分析

COVID-19のパンデミックと世界各国でのロックダウンにより、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局(FDA)は、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準(GCP)を遵守し、試験の完全性に対するリスクを最小限に抑えるための一般的な考慮事項を含むガイドラインを発表しました。

ロシア・ウクライナ紛争の影響分析

ロシア・ウクライナ紛争は、世界の画像診断市場に中程度の影響を及ぼすと考えられます。ウクライナの診療所はロシア軍からの侵攻を受け続けているが、死者数の増加や限られた医療援助に追われています。あらゆる種類のヘルスケア支援が不足しています。また、基本的な材料の輸出入の重要性は、予測期間における世界の画像診断市場の成長に若干の影響を与えると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 新興国市場の開拓の増加
      • 慢性疾患の増加
    • 抑制要因
      • 高コスト
    • 機会
      • 研究資金の増加
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 タイプ別

  • X線
    • アナログイメージング
    • デジタルイメージング
  • MRI
    • 低磁場MRIスキャナー
    • 高磁場MRIスキャナー
    • 中磁場MRIスキャナー
  • 核医学
    • シンチグラフィー
    • PETイメージング
    • SPECTイメージング
  • SPECTイメージング
  • 超音波検査
    • 2D超音波
    • 3D/4D超音波
    • ドップラーイメージング
  • トモグラフィ
    • ハイエンドスライスCTスキャナー
    • ミッドエンドスライスCTスキャナー
    • ローエンドCTスキャナー
  • 触覚イメージング
  • 機能的近赤外分光法

第8章 アプリケーション別

  • 整形外科
  • 神経学
  • 腫瘍学
  • 心臓病学
  • その他

第9章 エンドユーザー別

  • 病院
  • 画像診断センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
      • その他アジア太平洋地域
  • 中東およびアフリカ
    • 主な地域別ダイナミクス

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Siemens Healthcare
  • Carestream Health Inc.
  • Hitachi Medical Corporation
  • Canon Toshiba Medical Systems Corporation
  • Hologic Corporation
  • Philips Healthcare
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Mindray

第13章 付録

目次
Product Code: MI390

Market Overview

The Global Diagnostic Imaging Market reached US$ 27.4 billion in 2022 and is expected to reach US$ 41.6 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period (2023-2030). The rising number of people with chronic diseases and pathological diseases has raised the need for avant-garde medical imaging procedures.

The rising need for diagnostic devices that can detect conditions earlier has increased the market for progressive medical imaging devices. With the improvement in technology, the reporting period which is needed after the image has been reviewed has also decreased extensively. The precision and accuracy of imaging devices have even improved with the upgrade in technology.

Market Dynamics

Increasing Product Approvals Drive the Growth of the Diagnostic Imaging Market

The increasing market developments are expected to boost the global medical imaging market growth in the forecast period. For instance, in April 2022, Wipro GE Healthcare introduced the next-generation Revolution Aspire CT scanner. Revolution Aspire is an advanced imaging solution developed and fabricated end-to-end in India.

Moreover, in February 2023, FUJIFILM India, a frontier in healthcare imaging and information systems, expanded its product and solutions portfolio at the 75th National Conference of the Indian Radiological and Imaging Association (IRIA). The new range possesses ultrasound system Arietta 850 DeepInsight and Arietta 650 DeepInsight along with the new MRI machine APERTO Lucent Non-DICOM printer APEOS. Further, the corporation even presented "FUJIFILM Connect" a service & support mobile application.

The Increase in Research Funding is Expected to Present the Global Diagnostic Imaging Market with Growth Opportunities

The increasing research funding is expected to present the global diagnostic imaging market with prospective growth opportunities in the upcoming years. For instance, the assignment of the R&E Foundation is to fund the future of radiology by designing researchers and helping lifelong ingenious investigation and education. Since the Foundation's beginning in 1984, it has granted more than 1,600 grants. That's $70 million in funding for radiology investigation and enhancing patient care.

The Shortage of Skilled Personnel and Efficient Training Programs is Estimated to Hamper the Global Diagnostic Imaging Market During the Forecast Period

The shortage of trained personnel is a considerable challenge facing the diagnostic imaging industry. Diagnostic imaging is a highly specialized field requiring specialized training and expertise, and there is a growing shortage of skilled personnel.

One of the primary reasons for the shortage of skilled personnel is the lack of investment in education and training programs for diagnostic imaging. Many universities and colleges do not offer specialized programs in diagnostic imaging, and there is a limited number of training programs available for diagnostic imaging.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global diagnostic imaging market, as there is a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of healthcare assistance. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global diagnostic imaging market growth in the forecast period.

Segment Analysis

The global diagnostic imaging market is segmented based on product type, disease type, end-user, and region.

The Tomography Type of Diagnostic Imaging is Estimated to Dominate the Global Diagnostic Imaging Market

The tomography type of diagnostic imaging is expected to hold around 37.8% of the global market share owing to the increasing product introductions into the market. For instance, in May 2023, Royal Philips, a multinational leader in health technology, launched the Philips CT 3500, a new high-throughput CT system targeting the requirements of everyday radiology and high-volume screening schedules.

Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing characteristics that aid to provide the consistency, rate, and first-time-right image grade ought for assured diagnoses by clinicians and improved recovery on investment in the highly selective, high-volume care environments.

Moreover, in March 2022, at the 74th National Conference, IRIA 2022, Bengaluru, Siemens Healthineers introduced its latest product MAGNETOM Free. Star and NAEOTOM Alpha in MRI and CT pipeline. These product takeoffs supported the corporation broaden its consumer ground by delivering state-of-the-art medical imaging technology.

Geographical Analysis

Europe is Estimated to Hold 28.6% of the Market Share Owing to the Increasing Chronic Diseases Prevalence in this Region

Owing to the increasing cases of chronic diseases in this region, Europe is estimated to dominate the global market holding around 28.6% of the market by 2030. For instnace, according to the European Heart Network AISBL, annually cardiovascular conditions (CVD) causes 3.9 million casualties in Europe and more than 1.8 million deaths in the European Union (EU), CVD makes up for over 45% of all deaths in Europe and 37% of all deaths in the EU.

CVD is the primary reason for death in males in all whereas 12 nations of Europe and is the primary reason for death in females in all but two countries. Death rates from both ischaemic heart disease (IHD) and stroke are typically more increased in Central and Eastern Europe compared to Northern, Southern, and Western Europe.

Competitive Landscape

The major global players in the diagnostic imaging market include: GE Healthcare, Siemens Healthcare, Carestream Health Inc., Hitachi Medical Corporation, Canon Toshiba Medical Systems Corporation, Hologic Corporation, Philips Healthcare, Fujifilm Holdings Corporation, and Shimadzu Corporation, among others.

Why Purchase the Report?

  • To visualize the global diagnostic imaging market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of diagnostic imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in excel consisting of key products of all the major players.

The global diagnostic imaging market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Research Funding
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. X-Ray *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 7.2.2.1. Analog Imaging
      • 7.2.2.2. Digital Imaging
  • 7.3. MRI
    • 7.3.1. Low-Field MRI Scanners
    • 7.3.2. High-Field MRI Scanners
    • 7.3.3. Mid-Field MRI Scanners
  • 7.4. Nuclear Medicine
    • 7.4.1. Scintigraphy
    • 7.4.2. PET Imaging
    • 7.4.3. SPECT Imaging
  • 7.5. SPECT Imaging
  • 7.6. Ultrasound
    • 7.6.1. 2D Ultrasound
    • 7.6.2. 3D/4D Ultrasound
    • 7.6.3. Doppler Imaging
  • 7.7. Tomography
    • 7.7.1. High-End Slice CT Scanners
    • 7.7.2. Mid-End Slice CT Scanners
    • 7.7.3. Low-End Slice CT Scanners
  • 7.8. Tactile Imaging
  • 7.9. Functional near Infrared Spectroscopy

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Neurology
  • 8.4. Oncology
  • 8.5. Cardiology
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostics Imaging Centers
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare
  • 12.3. Carestream Health Inc.
  • 12.4. Hitachi Medical Corporation
  • 12.5. Canon Toshiba Medical Systems Corporation
  • 12.6. Hologic Corporation
  • 12.7. Philips Healthcare
  • 12.8. Fujifilm Holdings Corporation
  • 12.9. Shimadzu Corporation
  • 12.10. Mindray

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us